Market Research Report Raynauds Disease Pipeline Review Report 2017

Raynauds Disease Pipeline Review and Industry
Report 2017 - Market Research Hub
Market Research Hub (MRH) has recently announced the addition of a fresh report,
titled “Raynauds Disease - Pipeline Review, H1 2017 market research hub” to its
report offerings. The report provides comprehensive information on the therapeutics
under development for Raynauds Disease (Cardiovascular), complete with analysis
by stage of development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type.
Request Free Sample Report:
http://www.marketresearchhub.com/enquiry.php?type=S&repid=1027631
Market Research Hub’s latest Pharmaceutical and Healthcare disease pipeline guide
Raynauds Disease Pipeline Review, H1 2017, provides an overview of the Raynauds
Disease (Cardiovascular) pipeline landscape.
Raynauds disease is a common condition that affects the blood supply to certain
parts of the body, usually the fingers and toes. Predisposing factors include age,
gender, family history and smoking. Symptoms include fingers, toes, ears, or nose
to become white, and then turn blue. Treatment includes vasodilator, alpha blockers
and calcium channel blockers.
Report Highlights
Market Research Hub‘s Pharmaceutical and Healthcare latest pipeline guide
Raynauds Disease Pipeline Review, H1 2017, provides comprehensive information
on the therapeutics under development for Raynauds Disease (Cardiovascular),